Targovax ASA (GB:0RIS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circio Holding ASA has announced the increase of its share capital following the conversion of convertible bonds by Atlas Special Opportunities, LLC, resulting in the issuance of 1,181,009 new shares. The company is actively developing novel RNA therapeutics and a promising cancer vaccine, TG01, currently undergoing clinical trials for various cancers. Circio’s proprietary circVec technology promises to enhance the efficacy of DNA and virus-based therapeutics.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
